List of insiders holdings for Cellular Biomedicine Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
EastBridge Investment Group Corp CEO 10% Owner | 2009-02-03 10:32:06 | 50,640,180 0 | 50,640,180 | Form 4 |
Klein Norman Paul II Director | 2013-06-06 14:04:19 | 13,561,390 0 | 13,561,390 | Form 5 |
PROVIDENTIAL HOLDINGS INC 10% Owner | 2007-02-16 19:03:04 | 10,000,000 0 | 10,000,000 | Form 3 |
dembinski leo joseph Director | 2009-03-13 16:36:43 | 4,100,000 0 | 4,100,000 | Form 4 |
Global Health Investment Holdings Ltd. Former 10% owner | 2015-11-25 11:57:37 | 2,402,299 0 | 2,402,299 | Form 4 |
Sailing Capital Overseas Investments Fund LP 10% Owner | 2020-04-01 09:39:37 | 1,712,920 0 | 1,712,920 | Form 13D |
Maplebrook Ltd 10% Owner | 2020-02-28 16:02:20 | 0 1,104,933 | 1,104,933 | Form 3 |
Mission Right Ltd 10% Owner | 2019-11-18 21:56:28 | 0 1,030,640 | 1,030,640 | Form 3 |
Pan Viktor 10% Owner | 2020-02-28 16:01:52 | 0 1,000,000 | 1,000,000 | Form 3 |
Leung Pak To Venture Garden Ltd Full Moon Resources Ltd 10% Owner | 2018-03-01 15:26:52 | 710,452 0 | 710,452 | Form 13G |
Zhou Zheng 10% Owner | 2020-02-28 16:00:28 | 0 371,007 | 371,007 | Form 3 |
TF Venture Capital Management Co. Ltd. Winsor Capital Ltd Chiang Chen Hsiu-Lien 10% Owner | 2020-04-01 09:37:43 | 358,974 0 | 358,974 | Form 13D |
HILLHOUSE CAPITAL ADVISORS LTD. 10% Owner | 2020-06-24 16:38:42 | 235,214 0 | 235,214 | Form 13D |
Cao Wei (William) Director | 2016-04-14 11:08:21 | 214,472 0 | 214,472 | Form 4 |
Wong Keith Director | 2014-05-30 09:42:44 | 169,200 24,515 | 193,715 | Form 4 |
Zhang Li Helen 10% Owner | 2019-11-20 21:56:27 | 103,372 16,526 | 119,898 | Form 3 |
Yao Yihong Chief Scientific Officer | 2021-02-19 15:12:58 | 88,549 0 | 88,549 | Form 4 |
Dai Chengxiang 10% Owner | 2019-11-20 21:53:22 | 50,536 13,750 | 64,286 | Form 3 |
Patel Nadir Director | 2018-05-22 16:10:38 | 38,701 0 | 38,701 | Form 4 |
Meng Xia Chief Operating Officer | 2018-02-13 18:05:29 | 26,104 0 | 26,104 | Form 5 |
OPEA SRL Director | 2020-02-28 16:01:30 | 0 21,052 | 21,052 | Form 3 |
Bolocan David Director | 2014-07-03 18:59:40 | 10,000 0 | 10,000 | Form 4 |
Dai Jianping Director | 2013-04-02 20:42:19 | 5,300 0 | 5,300 | Form 4 |
Hau Bosun Director | 2018-05-22 16:10:43 | 4,784 0 | 4,784 | Form 4 |
Auerbach Jeffrey H. Director | 2014-07-15 16:47:00 | 4,000 0 | 4,000 | Form 3 |
WANG RICHARD L Chief Operating Officer | 2015-06-05 18:10:22 | 500 0 | 500 | Form 3 |
Liu Tony CEO, CFO | 2021-02-19 15:44:36 | 0 0 | 0 | Form 13D |
Au Chun Kwok Alan Director | 2021-02-19 15:13:22 | 0 0 | 0 | Form 4 |
Ji Gang Jacky Director | 2021-02-19 15:13:16 | 0 0 | 0 | Form 4 |
Belmont Terry Director | 2021-02-19 15:13:15 | 0 0 | 0 | Form 4 |
Zhou Hansheng Director | 2021-02-19 15:13:10 | 0 0 | 0 | Form 4 |
Schafer Edward T Director | 2021-02-19 15:13:09 | 0 0 | 0 | Form 4 |
Liu Wen Tao Director | 2021-02-19 15:13:05 | 0 0 | 0 | Form 4 |
Dangdal International Group Co. Ltd 10% Owner | 2021-02-19 19:50:47 | 0 0 | 0 | Form 13D |
Chan Andrew K Ch Legal Ofr, Corp Dev & Sec | 2021-02-19 15:12:54 | 0 0 | 0 | Form 4 |
NOVARTIS PHARMA AG NOVARTIS AG 10% Owner | 2021-02-23 19:57:25 | 0 0 | 0 | Form 13D |
Xu Guo-Tong Director | 2015-02-24 15:30:40 | 0 0 | 0 | Form 3 |